RPG Life Sciences

RPG Life Sciences

RPGLIFE.NS
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

RPGLIFE.NS · Stock Price

INR 2,492.00+459.10 (+22.58%)
Market Cap: $431.2M

Historical price data

Overview

RPG Life Sciences operates as a formulation and manufacturing-driven pharmaceutical company, aiming to provide high-quality, affordable medicines across key therapeutic segments in India. Its core achievements include building a robust, diversified product portfolio, establishing extensive distribution reach, and maintaining regulatory-compliant manufacturing capabilities. The company's strategy leverages its position within the RPG group to capitalize on India's demographic and healthcare infrastructure tailwinds, focusing on portfolio expansion and operational efficiency to drive growth.

Critical CareWomen's HealthMetabolic Disorders

Technology Platform

A formulation and drug delivery platform focused on developing value-added generic pharmaceuticals, including modified-release systems, fixed-dose combinations, and complex injectables, supported by in-house manufacturing and regulatory expertise.

Opportunities

The company is poised to benefit from India's expanding healthcare access, rising prevalence of chronic diseases, and government support for domestic manufacturing.
Deepening penetration in semi-urban/rural markets and launching new formulations in core therapeutic areas present clear growth pathways.

Risk Factors

Key risks include intense price competition and government price controls, regulatory compliance challenges for manufacturing, dependence on the concentrated Indian market, and execution risk in the product launch pipeline.

Competitive Landscape

RPG competes with large domestic pharma giants, other mid-cap specialists, and multinational corporations. Its advantages lie in its RPG group affiliation, focused therapeutic strategy, in-house manufacturing control, and an extensive, established distribution network.